Your browser doesn't support javascript.
loading
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study.
Carpenter, Paul A; Kang, Hyoung Jin; Yoo, Keon Hee; Zecca, Marco; Cho, Bin; Lucchini, Giovanna; Nemecek, Eneida R; Schultz, Kirk R; Stepensky, Polina; Chaudhury, Sonali; Oshrine, Benjamin; Khaw, Seong Lin; Harris, Andrew C; Verna, Marta; Zubarovskaya, Liudmila; Lee, Yihua; Wahlstrom, Justin; Styles, Lori; Shaw, Peter J; Dalle, Jean-Hugues.
Afiliação
  • Carpenter PA; Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: pcarpent@fredhutch.org.
  • Kang HJ; Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Wide River Institute of Immunology, Seoul National University Children's Hospital, Seoul, South Korea.
  • Yoo KH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Zecca M; Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Cho B; Department of Pediatrics, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Lucchini G; Great Ormond Street Hospital, London, United Kingdom.
  • Nemecek ER; Oregon Health & Science University, Portland, Oregon.
  • Schultz KR; University of British Columbia, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
  • Stepensky P; Department of Bone Marrow Transplantation, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Chaudhury S; Hematology, Oncology & Stem Cell Transplant Program, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois.
  • Oshrine B; Johns Hopkins All Children's Cancer & Blood Disorders Institute, St. Petersburg, Florida.
  • Khaw SL; Royal Children's Hospital, Parkville, Victoria, Australia.
  • Harris AC; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Verna M; MBBM Foundation, Monza, Italy.
  • Zubarovskaya L; St. Petersburg State Medical University, St. Petersburg, Russia.
  • Lee Y; Pharmacyclics LLC, an AbbVie Company, South San Francisco, California.
  • Wahlstrom J; Pharmacyclics LLC, an AbbVie Company, South San Francisco, California.
  • Styles L; Pharmacyclics LLC, an AbbVie Company, South San Francisco, California.
  • Shaw PJ; The Children's Hospital Westmead, Sydney, New South Wales, Australia.
  • Dalle JH; Pediatric Immuno-Hematology Unit, Robert Debre Hospital, Université de Paris, Paris, France.
Transplant Cell Ther ; 28(11): 771.e1-771.e10, 2022 11.
Article em En | MEDLINE | ID: mdl-36044977
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Child / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article